{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:22:47Z","timestamp":1789665767706,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":1352,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1194\/jlr.m068395","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T08:17:17Z","timestamp":1479284237000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1194\/jlr.f110.005975","source":"Crossref","is-referenced-by-count":21,"title":["Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S]"],"prefix":"10.1016","volume":"58","author":[{"given":"Tobias","family":"Kroon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Baccega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Ols\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gabrielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M068395_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M068395_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/dc15-1876","article-title":"Metabolic impact of nonalcoholic steatohepatitis in obese patients with type 2 diabetes","volume":"39","author":"Lomonaco","year":"2016","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.M068395_bib3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","article-title":"Lipids and lipoproteins in patients with type 2 diabetes","volume":"27","author":"Krauss","year":"2004","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.M068395_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bse0420089","article-title":"Fatty acid metabolism in adipose tissue, muscle and liver in health and disease","volume":"42","author":"Frayn","year":"2006","journal-title":"Essays Biochem."},{"key":"10.1194\/jlr.M068395_bib5","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1210\/en.2008-0059","article-title":"Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids","volume":"149","author":"Ge","year":"2008","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.M068395_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.01.029","article-title":"Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing","volume":"727","author":"Sakurai","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1194\/jlr.M068395_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-pharmtox-011613-135945","article-title":"Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors","volume":"54","author":"Offermanns","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1194\/jlr.M068395_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.0954-6820.1962.tb07203.x","article-title":"The effect of nicotinic acid on the plasma free fatty acid: demonstration of a metabolic type of sympathicolysis","volume":"172","author":"Carlson","year":"1962","journal-title":"Acta Med. Scand."},{"key":"10.1194\/jlr.M068395_bib9","doi-asserted-by":"crossref","first-page":"E1012","DOI":"10.1152\/ajpendo.00650.2010","article-title":"Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue","volume":"300","author":"Oh","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1194\/jlr.M068395_bib10","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1194\/jlr.M058149","article-title":"Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in rats","volume":"56","author":"Kroon","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M068395_bib11","doi-asserted-by":"crossref","first-page":"148ra115","DOI":"10.1126\/scitranslmed.3003877","article-title":"Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression","volume":"4","author":"Lauring","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1194\/jlr.M068395_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/dom.12255","article-title":"Postprandial effects of long-term niacin\/laropiprant use on glucose and lipid metabolism and on cardiovascular risk in patients with polycystic ovary syndrome","volume":"16","author":"Aye","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1194\/jlr.M068395_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0034-1372600","article-title":"Nicotinic acid effects on insulin sensitivity and hepatic lipid metabolism: an in vivo to in vitro study","volume":"46","author":"Blond","year":"2014","journal-title":"Horm. Metab. Res."},{"key":"10.1194\/jlr.M068395_bib14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2147\/IJWH.S69908","article-title":"Niacin increased glucose, insulin, and C-peptide levels in sedentary nondiabetic postmenopausal women","volume":"6","author":"Koh","year":"2014","journal-title":"Int. J. Womens Health."},{"key":"10.1194\/jlr.M068395_bib15","doi-asserted-by":"crossref","first-page":"154014","DOI":"10.1155\/2015\/154014","article-title":"Effect of extended-release niacin\/laropiprant combination on plasma adiponectin and insulin resistance in Chinese patients with dyslipidaemia","volume":"2015","author":"Hu","year":"2015","journal-title":"Dis. Markers."},{"key":"10.1194\/jlr.M068395_bib16","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1161\/ATVBAHA.115.306136","article-title":"Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus","volume":"35","author":"Ooi","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M068395_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/ATVBAHA.115.306834","article-title":"Extended-release niacin\/laropiprant improves overall efficacy of postprandial reverse cholesterol transport","volume":"36","author":"El Khoury","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M068395_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/heartjnl-2015-308055","article-title":"Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials","volume":"102","author":"Goldie","year":"2016","journal-title":"Heart."},{"key":"10.1194\/jlr.M068395_bib20","series-title":"In Dyslipidemias, Contemporary, Endocrinology.","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-1-60761-424-1_26","article-title":"Niacin: risk benefits and role in treating dyslipidemias.","author":"Guyton","year":"2015"},{"key":"10.1194\/jlr.M068395_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10928-013-9335-z","article-title":"Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions","volume":"40","author":"Ahlstrom","year":"2013","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1194\/jlr.M068395_bib22","doi-asserted-by":"crossref","first-page":"305347","DOI":"10.1155\/2013\/305347","article-title":"The PPARalpha\/gamma agonist, tesaglitazar, improves insulin mediated switching of tissue glucose and free fatty acid utilization in vivo in the obese Zucker rat","volume":"2013","author":"Wallenius","year":"2013","journal-title":"PPAR Res."},{"key":"10.1194\/jlr.M068395_bib23","doi-asserted-by":"crossref","first-page":"R938","DOI":"10.1152\/ajpregu.00252.2005","article-title":"Tesaglitazar, a dual PPAR{alpha}\/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats","volume":"289","author":"Oakes","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1194\/jlr.M068395_bib24","series-title":"Biometry: The Principles and Practice of Statistics in Biological Research.","author":"Sokal Robert","year":"1969"},{"key":"10.1194\/jlr.M068395_bib25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2337\/diabetes.50.5.1158","article-title":"Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability","volume":"50","author":"Oakes","year":"2001","journal-title":"Diabetes."},{"key":"10.1194\/jlr.M068395_bib26","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1152\/ajpendo.2000.279.1.E50","article-title":"Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women","volume":"279","author":"Wang","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1194\/jlr.M068395_bib27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M068395_bib28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.M068395_bib29","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1128\/MCB.00422-15","article-title":"The role of PDE3B phosphorylation in the inhibition of lipolysis by insulin","volume":"35","author":"DiPilato","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1194\/jlr.M068395_bib30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2005.01.073","article-title":"Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia","volume":"95","author":"Vega","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.M068395_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1677\/jme.1.01499","article-title":"Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes","volume":"33","author":"Watt","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1194\/jlr.M068395_bib32","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1210\/en.2012-1330","article-title":"A fall in plasma free fatty acid (FFA) level activates the hypothalamic-pituitary-adrenal axis independent of plasma glucose: evidence for brain sensing of circulating FFA","volume":"153","author":"Oh","year":"2012","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.M068395_bib33","doi-asserted-by":"crossref","first-page":"420754","DOI":"10.1155\/2013\/420754","article-title":"Roles of fatty acid oversupply and impaired oxidation in lipid accumulation in tissues of obese rats","volume":"2013","author":"Oakes","year":"2013","journal-title":"J. Lipids."},{"key":"10.1194\/jlr.M068395_bib34","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/mol.112.081307","article-title":"Identification and characterization of distinct C-terminal domains of the human hydroxycarboxylic acid receptor-2 that are essential for receptor export, constitutive activity, desensitization, and internalization","volume":"82","author":"Li","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1194\/jlr.M068395_bib35","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1194\/jlr.M300403-JLR200","article-title":"Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells","volume":"45","author":"Ganji","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M068395_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MPA.0b013e31820b4b23","article-title":"Nicotinic acid inhibits glucose-stimulated insulin secretion via the g protein-coupled receptor PUMA-G in murine islet \u03b2 cells","volume":"40","author":"Li","year":"2011","journal-title":"Pancreas."},{"key":"10.1194\/jlr.M068395_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2015.01.029","article-title":"Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets","volume":"404","author":"Chen","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1194\/jlr.M068395_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/ATVBAHA.111.241836","article-title":"Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms","volume":"32","author":"Digby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M068395_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbalip.2010.10.001","article-title":"Hormone-sensitive lipase modulates adipose metabolism through PPAR\u03b3.","volume":"1811","author":"Shen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1194\/jlr.M068395_bib40","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/sj.ijo.0802911","article-title":"Lessons from human mutations in PPAR\u03b3","volume":"29","author":"Hegele","year":"2005","journal-title":"Int. J. Obes. (Lond.)."},{"key":"10.1194\/jlr.M068395_bib41","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1315496","article-title":"Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes","volume":"370","author":"Albert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M068395_bib42","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1128\/MCB.24.3.1313-1323.2004","article-title":"Tissue-selective, bidirectional regulation of PEX11 alpha and perilipin genes through a common peroxisome proliferator response element","volume":"24","author":"Shimizu","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1194\/jlr.M068395_bib43","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1074\/jbc.M110158200","article-title":"Dual promoter structure of mouse and human fatty acid translocase\/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands","volume":"277","author":"Sato","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.M068395_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/BJ20031340","article-title":"Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins","volume":"382","author":"Schachtrup","year":"2004","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.M068395_bib45","doi-asserted-by":"crossref","first-page":"e1001485","DOI":"10.1371\/journal.pbio.1001485","article-title":"Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass","volume":"11","author":"Girousse","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1194\/jlr.M068395_bib46","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"AIM-HIGH Investigators,. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"E.","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M068395_bib47","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.M068395_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"HPS2-THRIVE Collaborative Group,. Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M068395_bib50","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jacc.2013.07.023","article-title":"Relationship of lipoproteins to cardiovascular events: the AIM-HIGH trial (Atherothrombosis intervention in metabolic syndrome with low HDL\/high triglycerides and impact on global health outcomes)","volume":"62","author":"Guyton","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.M068395_bib51","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jacl.2015.01.008","article-title":"Is HPS2-THRIVE the death knell for niacin?","volume":"9","author":"Toth","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.M068395_bib52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/heartjnl-2015-308558","article-title":"Niacin: old habits die hard","volume":"102","author":"Haynes","year":"2016","journal-title":"Heart."},{"key":"10.1194\/jlr.M068395_bib53","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.amjmed.2012.03.017","article-title":"Extended-release niacin acutely suppresses postprandial triglyceridemia","volume":"125","author":"Usman","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1194\/jlr.M068395_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ajcn\/88.1.30","article-title":"Postprandial triglyceride responses to aerobic exercise and extended-release niacin","volume":"88","author":"Plaisance","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.M068395_bib55","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1002\/jps.24179","article-title":"Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers","volume":"103","author":"Kesisoglou","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1194\/jlr.M068395_bib56","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M068395_bib57","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1530\/acta.0.1270344","article-title":"Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus","volume":"127","author":"Vaag","year":"1992","journal-title":"Acta Endocrinolica."},{"key":"10.1194\/jlr.M068395_bib58","first-page":"2015","article-title":"Metabolic effects of long-term reduction in free fatty acids with acipimox in obesity: a randomized trial","volume":"101","author":"Makimura","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.M068395_bib59","first-page":"23","article-title":"Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration to healthy volunteers","volume":"48","author":"Efthymiopoulos","year":"1993","journal-title":"Therapie."},{"key":"10.1194\/jlr.M068395_bib60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003088-197803060-00001","article-title":"Clinical pharmacokinetics of hypolipidaemic drugs","volume":"3","author":"Gugler","year":"1978","journal-title":"Clin. Pharmacokinet."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520314346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520314346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M068395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T10:52:57Z","timestamp":1637405577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520314346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0022227520314346"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m068395","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}